中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
20期
65-66
,共2页
前哨淋巴结%乳腺癌%亚甲蓝
前哨淋巴結%乳腺癌%亞甲藍
전초림파결%유선암%아갑람
Sentinel lymph node biopsy(SLNB)%Breast cancer%Methylene blue
目的：以亚甲蓝为示踪剂探测乳腺癌前哨淋巴结( sentinel lymph node，SLN)，评价前哨淋巴结预测腋窝淋巴结转移的准确性。方法研究对象为自2011年6月份起我院普外科收治的100例cTis~3N0~2M0的乳腺癌患者。使用亚甲蓝为示踪剂，进行前哨淋巴结活检，之后行腋窝清扫。结果91例患者中成功地发现了SLN，SLN的数量为201个，平均每例2.20个。SLNB的灵敏度91.00%(91/100)，准确率96.70%(88/91)，假阴性率5.66%(3/53)，阳性预测值为100%。结论使用亚甲蓝作为示踪剂能准确找到前哨淋巴结，并能较好的预测腋窝淋巴结转移情况。
目的：以亞甲藍為示蹤劑探測乳腺癌前哨淋巴結( sentinel lymph node，SLN)，評價前哨淋巴結預測腋窩淋巴結轉移的準確性。方法研究對象為自2011年6月份起我院普外科收治的100例cTis~3N0~2M0的乳腺癌患者。使用亞甲藍為示蹤劑，進行前哨淋巴結活檢，之後行腋窩清掃。結果91例患者中成功地髮現瞭SLN，SLN的數量為201箇，平均每例2.20箇。SLNB的靈敏度91.00%(91/100)，準確率96.70%(88/91)，假陰性率5.66%(3/53)，暘性預測值為100%。結論使用亞甲藍作為示蹤劑能準確找到前哨淋巴結，併能較好的預測腋窩淋巴結轉移情況。
목적：이아갑람위시종제탐측유선암전초림파결( sentinel lymph node，SLN)，평개전초림파결예측액와림파결전이적준학성。방법연구대상위자2011년6월빈기아원보외과수치적100례cTis~3N0~2M0적유선암환자。사용아갑람위시종제，진행전초림파결활검，지후행액와청소。결과91례환자중성공지발현료SLN，SLN적수량위201개，평균매례2.20개。SLNB적령민도91.00%(91/100)，준학솔96.70%(88/91)，가음성솔5.66%(3/53)，양성예측치위100%。결론사용아갑람작위시종제능준학조도전초림파결，병능교호적예측액와림파결전이정황。
ObjectiveTo evaluate the performance and feasibility of sentinel lymph node (SLN) in breast cancer using methylene blue as a tracer.MethodsIn our Hospital, from June 2011 100 patients with cTis~3N0~2M0 underwent SLNB, which is followed by standard axillary dissection. Methylene blue was used to detect the SLN during surgery.ResultsThe sentinel node is successfully identiifed in 91% (91/100) of the patients. The number of sentinel nodes was 201, average 2.20, the sensitivity in the study was 91.00% (91/100), accuracy was 96.70% (88/91), false negative rate 5.66% (3/53), positive predictive value of 100%. ConclusionsThis method using methylene blue as a tracer can accurately ifnd the sentinel lymph node, and can predict axillary lymph node metastasis.
